Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy

Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy

US Patent 8137675 · Granted Mar 20, 2012

Estimated economic value: $58,993,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining and reducing immunoresistance to botulinum toxin therapy using botul2012
Determining and reducing immunoresistance to a botulinum toxin therapy using bot2011
Determining and reducing immunoresistance to a botulinum toxin therapy using bot2011
Tolerogizing compositions comprising botulinum toxin type B peptides2010
Determining and reducing immunoresistance to a botulinum toxin therapy using bot2010
Determining and reducing immunoresistance to a Botulinum toxin therapy using Bot2010
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2009
Molecular-specific urokinase antibodies2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botul2008
Botulinum toxin A peptides and methods of predicting and reducing immunoresista2008
PVA or PEG conjugates of peptides for epitope-specific immunosuppression2000